Eliot Forster is PRESIDENT AND CEO of F-star Therapeutics Inc.
Person profile
Roles
F-star Therapeutics
PRESIDENT AND CEO
Protalix BioTherapeutics
Director
Address
Cambridge, United Kingdom
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Protalix BioTherapeutics, Inc.
15 Sep 23
3
Protalix BioTherapeutics, Inc.
15 Sep 23
4
F-star Therapeutics, Inc.
9 Mar 23
4
F-star Therapeutics, Inc.
2 Aug 22
4
F-star Therapeutics, Inc.
4 Apr 22
4
F-star Therapeutics, Inc.
11 Jan 22
4
F-star Therapeutics, Inc.
11 Mar 21
4
F-star Therapeutics, Inc.
2 Feb 21
4
F-star Therapeutics, Inc.
24 Nov 20
3
F-star Therapeutics, Inc.
24 Nov 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Sep 23 | PLX Protalix BioTherapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 1.75 | 85,715 | 150.00 k | 85,715 |
8 Mar 23 | FSTX F-star Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 7.12 | 73,959 | 526.59 k | 0 |
8 Mar 23 | FSTX F-star Therapeutics | Common Stock | Dispose U | No | No | 7.12 | 347,578 | 2.47 mm | 73,959 | |
8 Mar 23 | FSTX F-star Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.55 | 126,909 | 450.53 k | 0 |
8 Mar 23 | FSTX F-star Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.77 | 165,028 | 787.18 k | 0 |
8 Mar 23 | FSTX F-star Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.24 | 127,924 | 926.17 k | 0 |